DJIA 18,258.70 126.00 0.69%
NASDAQ 4,998.89 35.36 0.71%
S&P 500 2,114.94 10.44 0.50%
market minute promo

ImmunoGen (NASDAQ: IMGN)

7.85 0.25 (3.29%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IMGN $7.85 3.29%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.58
Previous Close $7.60
Daily Range $7.51 - $7.88
52-Week Range $5.34 - $17.76
Market Cap $675.9M
P/E Ratio -9.05
Dividend (Yield) $0.00 (0.0%)
Volume 737,927
Average Daily Volume 1,652,496
Current FY EPS -$0.67




Drug Makers

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website:

News & Commentary Rss Feed

In Case You Missed It, Researchers May Have Discovered a New Method to Treat Cancer

We know chemotherapy kills cancer cells, but it's also an indiscriminate killer of healthy cells. According to a new study released this past week, an entirely new treatment pathway could eliminate a significant portion of healthy cell death.

Cowen & Co Remains Bullish on Celldex Therapeutics Following FDA 'Breakthrough' Approval

5 Analyst Stock Picks Under $10 With Massive Upside Projections

Here's Why Oppenheimer Upgraded ImmunoGen To Outperform

Why ImmunoGen, Inc. Shares Rocketed Higher By 25% in January

ImmunoGen stock roars higher based on perhaps the most unlikely of sources: it's second-quarter earnings report. Find out what has Wall Street and investors so excited.

Stock To Watch: Immunogen (IMGN) In Perilous Reversal

Benzinga's Top #PreMarket Losers

Gulf Resources (GURE) Soars on Natural Gas Discovery, ImmunoGen (IMGN) and Synaptics (SYNA) ...

Update: ImmunoGen Earnings

ImmunoGen Shares Surge 30% Following Earnings

See More IMGN News...

IMGN's Top Competitors

IMGN $7.85 (3.29%)
Current stock: IMGN
AMGN $159.31 (1.01%)
Current stock: AMGN
GILD $103.78 (0.24%)
Current stock: GILD
BIIB $415.94 (1.55%)
Current stock: BIIB